Investigational drugs for treating agitation in persons with dementia.

Author: CaveroIcilio, CitromeLeslie, GarayRicardo P, GrossbergGeorge T, LlorcaPierre-Michel

Paper Details 
Original Abstract of the Article :
Agitation is common and distressing in persons with dementia, but safe, effective treatments remain elusive. In this review, the authors describe investigational compounds in ongoing or recently completed clinical trials for this indication and provide an opinion on how they may meet current therape...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/13543784.2016.1193155

データ提供:米国国立医学図書館(NLM)

The Agitation Desert: Searching for Relief in Dementia

Agitation, a distressing symptom often experienced by people with dementia, can be a challenging desert to navigate. This study explores the current landscape of investigational drugs being developed for this indication, providing a roadmap for finding new solutions.

A New Oasis of Hope for Agitation in Dementia

This research highlights the ongoing efforts to develop safe and effective treatments for agitation in dementia. It’s like searching for an oasis in the desert of this challenging condition, offering hope for improved quality of life for patients and their caregivers.

Finding Relief in the Desert of Dementia

This research underscores the importance of continued research into new treatments for agitation in dementia. It’s like exploring the desert landscape, searching for the best ways to alleviate the suffering caused by this debilitating condition.

Dr.Camel's Conclusion

This review provides valuable insights into the current landscape of investigational drugs for agitation in dementia. It’s a reminder that the quest for effective treatments continues, offering hope for a brighter future for those living with this challenging condition.
Date :
  1. Date Completed 2017-03-10
  2. Date Revised 2017-03-10
Further Info :

Pubmed ID

27232589

DOI: Digital Object Identifier

10.1080/13543784.2016.1193155

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.